UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought

Value in health, 2016-12, Vol.19 (8), p.921-928

2016

Volltextzugriff (PDF)

Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6

Value in health, 2012-09, Vol.15 (6), p.835-842

2012

Volltextzugriff (PDF)

Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility

Health economics, 2005-05, Vol.14 (5), p.487-496

2005

Volltextzugriff (PDF)

Reflecting the real value of health care resources in modelling and cost-effectiveness studies-The example of viral load informed differentiated care

PloS one, 2018-01, Vol.13 (1), p.e0190283-e0190283

2018

Volltextzugriff (PDF)

Economic analysis of the prevalence and clinical and economic burden of medication error in England

BMJ quality & safety, 2021-02, Vol.30 (2), p.96-105

2021

Volltextzugriff (PDF)

Value based pricing for NHS drugs: an opportunity not to be missed?

BMJ, 2008-02, Vol.336 (7638), p.251-254

International edition, 2008

Volltextzugriff (PDF)

Whither trial-based economic evaluation for health care decision making?

Health economics, 2006-07, Vol.15 (7), p.677-687

2006

Volltextzugriff (PDF)

A systematic review of continuous positive airway pressure for obstructive sleep apnoea–hypopnoea syndrome

Sleep medicine reviews, 2009-12, Vol.13 (6), p.427-436

2009

Volltextzugriff (PDF)

Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine

JAMA : the journal of the American Medical Association, 2016-09, Vol.316 (10), p.1093

2016

Volltextzugriff (PDF)

Optimising the Diagnosis of Prostate Cancer in the Era of Multiparametric Magnetic Resonance Imaging: A Cost-effectiveness Analysis Based on the Prostate MR Imaging Study (PROMIS)

European urology, 2018-01, Vol.73 (1), p.23-30

2018

Volltextzugriff (PDF)

Ideas About Resourcing Health Care in the United States: Can Economic Evaluation Achieve Meaningful Use?

Annals of internal medicine, 2021-01, Vol.174 (1), p.80-85

2021

Volltextzugriff (PDF)

Catalogue of EQ-5D Scores for the United Kingdom

Medical decision making, 2011-11, Vol.31 (6), p.800-804

2011

Volltextzugriff (PDF)

Model Parameter Estimation and Uncertainty Analysis: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group–6

Medical decision making, 2012-09, Vol.32 (5), p.722-732

2012

Volltextzugriff (PDF)

Endovascular versus Open Repair of Abdominal Aortic Aneurysm

The New England journal of medicine, 2010-05, Vol.362 (20), p.1863-1871

2010

Volltextzugriff (PDF)

Fondaparinux versus Enoxaparin in non–ST-elevation acute coronary syndromes: Short-term cost and long-term cost-effectiveness using data from the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trial

The American heart journal, 2009-05, Vol.157 (5), p.845-852

2009

Volltextzugriff (PDF)

Health Opportunity Costs: Assessing the Implications of Uncertainty Using Elicitation Methods with Experts

Medical decision making, 2020-05, Vol.40 (4), p.448-459

2020

Volltextzugriff (PDF)

The Value of Heterogeneity for Cost-Effectiveness Subgroup Analysis: Conceptual Framework and Application

Medical decision making, 2014-11, Vol.34 (8), p.951-964

2014

Volltextzugriff (PDF)

Authors’ Response to: “Health Opportunity Costs and Expert Elicitation: A Comment on Soares et al.” by Sampson, Firth, and Towse

Medical decision making, 2021-04, Vol.41 (3), p.258-260

2021

Volltextzugriff (PDF)

Establishing the Value of Diagnostic and Prognostic Tests in Health Technology Assessment

Medical decision making, 2018-05, Vol.38 (4), p.495-508

2018

Volltextzugriff (PDF)

Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting

The Lancet (British edition), 1998-10, Vol.352 (9138), p.1419-1425

1998

Volltextzugriff (PDF)

Future Directions for Cost-effectiveness Analyses in Health and Medicine

Medical decision making, 2018-10, Vol.38 (7), p.767-777

2018

Volltextzugriff (PDF)

Using value of information analysis to prioritise health research: some lessons from recent UK experience

PharmacoEconomics, 2006-01, Vol.24 (11), p.1055-1068

2006

Volltextzugriff (PDF)

ARE POLICY DECISIONS ON SURGICAL PROCEDURES INFORMED BY ROBUST ECONOMIC EVIDENCE? A SYSTEMATIC REVIEW

International journal of technology assessment in health care, 2014-10, Vol.30 (4), p.381-393

2014

Volltextzugriff (PDF)

How to design the cost‐effectiveness appraisal process of new healthcare technologies to maximise population health: A conceptual framework

Health economics, 2018-02, Vol.27 (2), p.e41-e54

2018

Volltextzugriff (PDF)

Using the Incremental Net Benefit Framework for Quantitative Benefit–Risk Analysis in Regulatory Decision-Making—A Case Study of Alosetron in Irritable Bowel Syndrome

Value in health, 2010-06, Vol.13 (4), p.411-417

2010

Volltextzugriff (PDF)

1 – 25 von 140

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(130)
Mit Volltextzugriff
(116)

Publikationsform

Sprache

Englisch
(140)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought

Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6

Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility

Reflecting the real value of health care resources in modelling and cost-effectiveness studies-The example of viral load informed differentiated care

Economic analysis of the prevalence and clinical and economic burden of medication error in England

Value based pricing for NHS drugs: an opportunity not to be missed?

Whither trial-based economic evaluation for health care decision making?

A systematic review of continuous positive airway pressure for obstructive sleep apnoea–hypopnoea syndrome

Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine

Optimising the Diagnosis of Prostate Cancer in the Era of Multiparametric Magnetic Resonance Imaging: A Cost-effectiveness Analysis Based on the Prostate MR Imaging Study (PROMIS)

Ideas About Resourcing Health Care in the United States: Can Economic Evaluation Achieve Meaningful Use?

Catalogue of EQ-5D Scores for the United Kingdom

Model Parameter Estimation and Uncertainty Analysis: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group–6

Endovascular versus Open Repair of Abdominal Aortic Aneurysm

Fondaparinux versus Enoxaparin in non–ST-elevation acute coronary syndromes: Short-term cost and long-term cost-effectiveness using data from the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trial

Health Opportunity Costs: Assessing the Implications of Uncertainty Using Elicitation Methods with Experts

The Value of Heterogeneity for Cost-Effectiveness Subgroup Analysis: Conceptual Framework and Application

Authors’ Response to: “Health Opportunity Costs and Expert Elicitation: A Comment on Soares et al.” by Sampson, Firth, and Towse

Establishing the Value of Diagnostic and Prognostic Tests in Health Technology Assessment

Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting

Future Directions for Cost-effectiveness Analyses in Health and Medicine

Using value of information analysis to prioritise health research: some lessons from recent UK experience

ARE POLICY DECISIONS ON SURGICAL PROCEDURES INFORMED BY ROBUST ECONOMIC EVIDENCE? A SYSTEMATIC REVIEW

How to design the cost‐effectiveness appraisal process of new healthcare technologies to maximise population health: A conceptual framework

Using the Incremental Net Benefit Framework for Quantitative Benefit–Risk Analysis in Regulatory Decision-Making—A Case Study of Alosetron in Irritable Bowel Syndrome

Suchergebnisse filtern